Augmented Reality Training for Emergency Response

N/A

Waitlist Available

Research Sponsored by Thomas Caruso

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up duration of intervention (less than one hour)

Awards & highlights

No Placebo-Only Group

Summary

This trial evaluates how prehospital providers respond to simulation training using Augmented Reality (AR) technology.

Who is the study for?

This trial is for trainees and faculty aged 18 or older working at LPCH/SHC facilities, including community-based prehospital providers. It's not suitable for those who are pregnant, have a history of seizures or severe motion sickness, are clinically unstable, don't consent to participate, use corrective glasses (incompatible with AR headset), or currently experience nausea.

What is being tested?

The study tests the use of an Augmented Reality (AR) Headset as a training tool for prehospital providers. The focus is on how these providers interact with and accept AR technology during simulations that teach them about managing conditions like low blood sugar and acute lymphoblastic leukemia.

What are the potential side effects?

While the study itself may not cause direct side effects from medical interventions, participants should be aware that using an AR headset could potentially lead to discomfort such as eye strain or headaches due to its immersive nature.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ duration of intervention (less than one hour)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~duration of intervention (less than one hour)

This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of intervention (less than one hour) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Thematic Analysis of Post-Simulation Discussions

Secondary study objectives

Headset Ergonomics

System Usability Scale (SUS)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Augmented Reality Enhanced Simulation (Treatment group)Experimental Treatment1 Intervention

Each simulation will have between two and five participants. After consent, demographic data will be collected. Then, a study RA will fit a Magic Leap One (ML1) headsets (Magic Leap Inc., Plantation, FL) to participants. Following a scripted briefing, the instructor will also orient the participants to the ML1 headset for those in that group. After orienting the participant to the use of the headsets, the instructor will remain in a room separate from the participants, who will conduct the scenario outside. This will enable assessment of the feasibility of providing simulation instruction remotely. Prior to starting the scenario, the simulation instructor will conduct an orientation to review the core tenets of effective communication skills during prehospital care.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Augmented Reality Headset

2023

N/A

~150

Do I qualify?Apply below to find out